Skip to main content
. 2021 Oct 29;101(5):299–305. doi: 10.4174/astr.2021.101.5.299

Table 3. Adverse events.

graphic file with name astr-101-299-i003.jpg

Values are presented as number of occurrences (%).

Test group, patients treated by InnoSEAL Plus (InnoTherapy, Seoul, Korea); Comparator group, patients treated by TachoSil (Takeda Austria GmbH, Wien, Austria).

a)Fisher’s exact test.